CEL-SCI Announces Update on Arbitration against Former Clinical Research Organization

07:30 EST 13 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
CEL-SCI Corporation (NYSE American:CVM) announced today an update on its arbitration with its former clinical research organization (CRO). The last witness in the arbitration hearing testified on Wednesday, November 8, 2017, and...

Other Sources for this Article

CEL-SCI Corporation
Gavin de Windt, 703-506-9460


More From BioPortfolio on "CEL-SCI Announces Update on Arbitration against Former Clinical Research Organization"

Quick Search


Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Hearing, auditory perception, or audition is the ability to perceive sound by detecting vibrations, changes in the pressure of the surrounding medium through time, through an organ such as the ear. Sound may be heard through solid, liquid, or gaseous mat...